Eyepoint Pharmaceuticals Financials

Eyepoint Pharmaceuticals

EYPT • NASDAQ •

Values in thousands	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Revenue	$11,684	$14,028	$15,202	$9,105
Gross Profit	10,925	13,030	14,000	7,313
EBITDA	-33,018	-16,242	-12,612	-21,138
EBIT	-33,321	-16,354	-14,398	-22,761
Net Income	-29,284	-14,099	-12,612	-22,920
Net Change In Cash	11,684	14,028	15,202	9,105
Cost of Revenue				33,832
Free Cash Flow	-32,365	-23,992	-16,924	56,627
Cash	271,013	281,263	133,035	139,597
Basic Shares	52,913	42,168	38,341	37,576

Values in thousands	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	$46,018	$41,404	$36,939	$34,437
Gross Profit	41,386	33,078	28,762	28,613
EBITDA	-73,198	-74,757	-52,524	-34,772
EBIT	-73,662	-78,938	-55,276	-37,290
Net Income	-70,795	-124,512	-63,915	-52,651
Net Change In Cash	46,018	41,404	36,939	34,437
Cost of Revenue		-82,960	133,684	22,695
Free Cash Flow	-1,608	-67,155	-50,253	-14,797
Cash	281,263	95,633	178,593	44,909
Basic Shares	38,904	37,317	28,758	12,836